Your browser doesn't support javascript.
loading
The LEGACy study: a European and Latin American consortium to identify risk factors and molecular phenotypes in gastric cancer to improve prevention strategies and personalized clinical decision making globally.
van Schooten, Tessa Suzanne; Derks, Sarah; Jiménez-Martí, Elena; Carneiro, Fatima; Figueiredo, Ceu; Ruiz, Erika; Alsina, Maria; Molero, Cristina; Garrido, Marcelo; Riquelme, Arnoldo; Caballero, Carmelo; Lezcano, Eva; O'Connor, Juan Manuel; Esteso, Federico; Farrés, Judith; Mas, José Manuel; Lordick, Florian; Vogt, Jeannette; Cardone, Antonella; Girvalaki, Charis; Cervantes, Andrés; Fleitas, Tania.
Afiliação
  • van Schooten TS; Amsterdam UMC-location VUMC, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Derks S; Oncode Institute, Utrecht, The Netherlands.
  • Jiménez-Martí E; Amsterdam UMC-location VUMC, Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Carneiro F; Oncode Institute, Utrecht, The Netherlands.
  • Figueiredo C; Instituto Investigación Sanitaria INCLIVA (INCLIVA), CIBERONC, Medical Oncology Department, Hospital Clínico Universitario de Valencia, Universitat de Valencia, Valencia, Spain.
  • Ruiz E; Institute of Pathology and Molecular Immunology of the University of Porto (IPATIMUP)/Institute of Research and Innovation in Health (i3S); Faculty of Medicine, University of Porto, Porto, Portugal.
  • Alsina M; Institute of Pathology and Molecular Immunology of the University of Porto (IPATIMUP)/Institute of Research and Innovation in Health (i3S); Faculty of Medicine, University of Porto, Porto, Portugal.
  • Molero C; Instituto Nacional de Cancerología (INCAN), Translational Medicine Laboratory & GI Cancer Department, Mexico City, Mexico.
  • Garrido M; Valld'Hebron Institute of Oncology (VHIO), Medical Oncology Department, Barcelona, Spain.
  • Riquelme A; Valld'Hebron Institute of Oncology (VHIO), Medical Oncology Department, Barcelona, Spain.
  • Caballero C; Pontificia Universidad Católica de Chile (PUC), Department of Hemato-Oncology, Santiago, Chile.
  • Lezcano E; Pontificia Universidad Católica de Chile (PUC), Department of Hemato-Oncology, Santiago, Chile.
  • O'Connor JM; GenPat, Asunción, Paraguay.
  • Esteso F; Instituto de Previsión Social, Asunción, Paraguay.
  • Farrés J; Instituto Alexander Fleming (IAF), Medical Oncology Department, Buenos Aires, Argentina.
  • Mas JM; Instituto Alexander Fleming (IAF), Medical Oncology Department, Buenos Aires, Argentina.
  • Lordick F; Anaxomics Biotech, S.L. (ANAX), Barcelona, Spain.
  • Vogt J; Anaxomics Biotech, S.L. (ANAX), Barcelona, Spain.
  • Cardone A; Universitaet Leipzig (ULEI), Medical Oncology Department, Leipzig, Germany.
  • Girvalaki C; Universitaet Leipzig (ULEI), Medical Oncology Department, Leipzig, Germany.
  • Cervantes A; European Cancer Patient Coalition (ECPC), Brussels, Belgium.
  • Fleitas T; European Cancer Patient Coalition (ECPC), Brussels, Belgium.
BMC Cancer ; 22(1): 646, 2022 Jun 13.
Article em En | MEDLINE | ID: mdl-35692051
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Gástricas Idioma: En Ano de publicação: 2022 Tipo de documento: Article